> ## Content Index
> Fetch the complete content index at: https://www.fdaweb.com/llms.txt
> Use this file to discover other available public pages before exploring further.

# Pediatric Drug Development Bill Introduced
- URL: https://www.fdaweb.com/pediatric-drug-development-bill-introduced/
- Published: 2023-12-07T12:00:00.000Z
- Updated: 2026-09-14T14:18:02.000Z
- Author: David McFarland
- Tags: Drugs, #legacy-id-D5155940

Reps. **Anna Eshoo** (D-CA) and **Michael McCaul** (R-TX) introduced 12/7 the bipartisan Innovation in Pediatric Drugs Act of 2023 to “ensure drugs for rare diseases are studied in children and drug companies are accountable for completing pediatric study requirements.” A [statement](https://eshoo.house.gov/media/press-releases/reps-eshoo-and-mccaul-introduce-bill-strengthen-development-pediatric-drugs?ref=fdaweb.com) from Eshoo says the bill would strengthen her Best Pharmaceuticals for Children Act (BCPA) and Pediatric Research Equality Act by:

- giving FDA additional authority to penalize companies that don’t complete required pediatric studies on time;
- requiring drugs for rare diseases to be studied in children; and
- doubling funding for the National Institutes of Health BPCA program to fund additional clinical trials and train additional personnel to help run trials.